ImmunoGen Names Richard Gregory As Research And Chief Scientific Officer

(RTTNews) - Biotechnology company ImmunoGen, Inc. (IMGN) announced the appointment of Richard Gregory as executive vice president, research and chief scientific officer (CSO), effective January 5, 2015.

Gregory will succeed John Lambert, will assume a newly created position of executive vice president, distinguished research fellow. He also remains a member of ImmunoGen's executive team. Lambert joined ImmunoGen in 1987 and has been its CSO since 2008.

Gregory brings to ImmunoGen over twenty-five years of scientific and research management experience, most recently serving as senior vice president and head of research for the Sanofi Genzyme Research & Development Center.

Gregory and Lambert will report directly to ImmunoGen President and CEO Daniel Junius.